Detalles de la búsqueda
1.
Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE Trial.
Circulation
; 149(23): 1802-1811, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583146
2.
Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
N Engl J Med
; 387(12): 1075-1088, 2022 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36129997
3.
Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes.
N Engl J Med
; 387(12): 1063-1074, 2022 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36129996
4.
Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
Diabetologia
; 67(7): 1328-1342, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38509341
5.
A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes.
Kidney Int
; 105(3): 618-628, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38101515
6.
Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study.
Cardiovasc Diabetol
; 23(1): 57, 2024 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38331813
7.
Empagliflozin and Risk of Incident Gout: Analysis from the EMPagliflozin Comparative Effectiveness and SafEty (EMPRISE) Cohort Study.
J Gen Intern Med
; 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710868
8.
Successful implementation of a stakeholder engagement program for pharmacoepidemiologic research.
Pharmacoepidemiol Drug Saf
; 33(1): e5727, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37985010
9.
Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study.
Ann Intern Med
; 176(8): 1067-1080, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37487215
10.
Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial.
Diabetologia
; 66(12): 2261-2274, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715820
11.
Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom.
Diabetes Obes Metab
; 25(10): 2980-2988, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37395339
12.
Self-Management and Glycemic Targets in Adult Haitian Immigrants With Type 2 Diabetes: Research Protocol.
Nurs Res
; 72(3): 211-217, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36929756
13.
Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685â616 adults.
Lancet
; 398(10296): 238-248, 2021 07 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34274065
14.
Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.
Am Heart J
; 254: 203-215, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36150454
15.
SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes.
Am J Kidney Dis
; 79(6): 858-867.e1, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34762974
16.
HbA1c-Triggered Endocrinology Electronic Consultation for Type 2 Diabetes Management.
J Gen Intern Med
; 37(5): 1081-1087, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34608564
17.
Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.
Diabetes Obes Metab
; 24(3): 442-454, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34729891
18.
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
Ann Intern Med
; 174(11): 1528-1541, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34570599
19.
Correction to: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD).
Diabetologia
; 63(8): 1667, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32409867
20.
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Diabetologia
; 63(2): 221-228, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31853556